A promising approach to develop a birth control pill for men

The world’s population has increased by more than 2.6-fold in the last 60 years. The growing trend continues – projections indicate that the number of people living on our planet will grow to 9 billion by 2037 from 8 billion in 2022. These numbers underscore the need for considering family planning; however, there have been limited breakthroughs in contraception in recent decades. Specifically for men, there are no oral contraceptive pills available. In a study...

MD Anderson and Sibylla Biotech announce strategic collaboration to discover and develop small-molecule protein degraders

Sibylla’s PPI-FIT technology joins with MD Anderson’s drug development resources and expertise to create protein-folding interfering degraders as cancer therapies   The University of Texas MD Anderson Cancer Center and Sibylla Biotech recently announced a strategic collaboration agreement to discover and develop novel small-molecule cancer therapies known as folding interfering degraders (FIDs), which disrupt the proper folding of target proteins and lead to their degradation.   Under the agreement, Sibylla and MD Anderson will jointly conduct discovery and development work from...

MJH footer logo with red letters

Medical Journal – Houston is the leading source of healthcare business news. With extremely relevant content, late-breaking news and monthly exclusives from industry experts, MJH News has created a winning combination of must-read editorial that physicians and hospital executives eagerly anticipate month after month. MJH News is the resource that provides everything they need in one place, and it is a high honor that they rely upon Medical Journal – Houston to keep their practice or hospital on the cutting edge.

Archives